News >

Patient Factors Critical to Treatment Selection in Prostate Cancer, RCC

Jessica Hergert
Published: Thursday, Dec 05, 2019

Kelvin Alexander Moses, MD, PhD, an associate professor of urology in the Department of Urology at Vanderbilt University Medical Center

Kelvin Alexander Moses, MD, PhD

In the era of precision medicine, an individual patient’s disease characteristics are critical to treatment selection in metastatic hormone-sensitive prostate cancer and renal cell carcinoma (RCC), said Kelvin Alexander Moses, MD, PhD. 
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication